Last Updated:
NameDesignationAppointment DateStatus
Raghava Reddy Kunam

Appointed as Managing Director since February 2009

Managing Director23-Feb-2009Current
Anil Reddy Kunam

Appointed as Director since March 2009

Director02-Mar-2009Current
Kunam Rajani

Appointed as Director since February 2009

Director23-Feb-2009Current
Sudhakar Reddy Chadalavada

Appointed as Director since March 2009

Director02-Mar-2009Current
Premium access

Complete director details

Unlock the complete director and KMP records available for Vijlak Pharma Limited.

  • Complete appointment and designation records
  • Current and past company associations
  • Shareholding and remuneration where filed

Verified entity values are shown only after access is granted.

People Timeline

Explore the timeline of key personnel in Vijlak Pharma Limited's leadership journey.

Loading...
Contact Details
  • Address Flat No. 204, Satya Sai Residency, Dharamkaram Road, Ameerpet,, Hyderabad Telangana, 500016, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 500016
  • Country India
  • Website -
  • Social Media
Frequently Asked Questions
You can contact Vijlak Pharma Limited through their registered address at Flat No. 204, Satya Sai Residency, Dharamkaram Road, Ameerpet,, Hyderabad Telangana, 500016, India, or via their website if available. Social media links are also provided where applicable.
The current directors of Vijlak Pharma Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • RAGHAVA REDDY KUNAM
  • SUDHAKAR REDDY CHADALAVADA
  • KUNAM RAJANI
  • ANIL REDDY KUNAM
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available